health
Pharmaceutical company asks to restore access to abortion pill by mail, to avoid 'chaos'
Pharmaceutical company asks to restore access to abortion pill by mail, to avoid 'chaos' Photo: iStock
TL;DR
- Danco, the first company approved to produce the abortion pill mifepristone, is seeking temporary restoration of access from the Supreme Court.
- The company warns that the suspension of sales will lead to 'immediate chaos' and uncertainty.
- A federal appeals court had temporarily reinstated a rule requiring in-person dispensing of abortion pills, prohibiting mail delivery.
- Mifepristone was used in 63% of abortions in the U.S. in 2023.
- The legal battle centers on regulations allowing telemedicine prescriptions and mail-order dispensing, which critics argue circumvent state abortion bans.
- The ACLU stated that restricting access through telemedicine endangers women in rural areas, those experiencing domestic violence, or those with disabilities.